Originator Organization Alentis Therapeutics AGStartup |
Active Organization Alentis Therapeutics AGStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CH | Alentis Therapeutics AGStartup | 15 Apr 2024 |